INS and metabolic syndrome: One paraprobiotic (pasteurized inactivated bacteria Akkermansia mucinphila) has been proven in a randomized, double-blind, placebo-controlled pilot study in overweight and obese subjects (n = 32) to improve insulin sensitivity and dyslipidemia and, to a lesser extent, decrease body weight and fat mass [199].